CoChat

A highly recurrent RPS27 5'UTR mutation in melanoma

Open access
Dutton-Regester, Ken, Gartner, Jared J., Emmanuel, Rafi, Qutob, Nouar, Davies, Michael A., Gershenwald, Jeffrey E., Robinson, William, Robinson, Steven, Rosenberg, Steven A., Scolyer, Richard A., Mann, Graham J., Thompson, John F., Hayward, Nicholas K., Samuels, Yardena · 2014 · Oncotarget
Cited by 52

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

// Ken Dutton-Regester 1,* , Jared J. Gartner 2,* , Rafi Emmanuel 3 , Nouar Qutob 3 , Michael A. Davies 4 , Jeffrey E. Gershenwald 4 , William Robinson 5 , Steven Robinson 5 , Steven A. Rosenberg 2 , Richard A. Scolyer 6,7,8 , Graham J. Mann 6,9 , John F. Thompson 6,10,11 , Nicholas K. Hayward 1 , Yardena Samuels 3 1 QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia 2 National Cancer Institute, NIH, MD, USA 3 Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel 4 The University of Texas MD Anderson Cancer Center, Houston, TX, USA 5 University of Colorado School of Medicine, Aurora, CO, USA 6 Melanoma Institute of Australia (formerly the Sydney Melanoma Unit), North Sydney,NSW, Australia 7 Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia 8 Discipline of Pathology, Sydney Medical School, The University of Sydney, NSW, Australia 9 University of Sydney at Westmead Millenium Institute, Westmead, NSW, Australia 10 Departments of Melanoma and Surgical Oncology, and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia 11 Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia * These authors contributed equally to this work Correspondence: Yardena Samuels, email: // Nicholas K. Hayward, email: // Keywords : Melanoma, somatic mutation, RPS27, exome sequencing, 5’ untranslated region Received : April 8, 2014 Accepted : May 30, 2014 Published : June 1, 2014 Abstract The incidence of melanoma continues to rise globally and is increasing at a rate greater than any other cancer. To systematically search for new genes involved in melanomagenesis, we collated exome sequencing data from independent melanoma cohort datasets, including those in the public domain. We identified recurrent mutations that may drive melanoma growth, survival or metastasis, and which may hold promise for the design of novel therapies to treat melanoma. These included a frequent recurrent (i.e. hotspot) mutation in the 5’ untranslated region of RPS27 in ~10% of samples. We show that the mutation expands the 5’TOP element, a motif known to regulate the expression of most of the ribosomal protein family, to which RPS27 belongs, and thus might sensitize the mutated transcript to growth-mediated regulation. This finding highlights not only the important role of non-protein coding genetic aberrations in cancer development but also their potential as novel therapeutic targets.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.2048

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 52

Metadata

Authors
Dutton-Regester, K., Gartner, J. J., Emmanuel, R., Qutob, N., Davies, M. A., Gershenwald, J. E., Robinson, W., Robinson, S., Rosenberg, S. A., Scolyer, R. A., Mann, G. J., Thompson, J. F., Hayward, N. K., & Samuels, Y.
Venue
Oncotarget
Published
2014-05-30
Volume
5
Issue
10
Pages
2912-2917
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2100344946
Cited by
52
References
7
FWCI
2.68
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.